Koneksa Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
55
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$45M
- Investors
-
11
Koneksa General Information
Description
Developer of a healthcare data analysis platform designed to improve clinical studies and disease research. The company's platform captures, monitors, and analyzes patient-generated data and outcomes in clinical studies in order to offer digital biomarkers for drug development, enabling healthcare professionals to develop medical drugs efficiently.
Contact Information
Website
www.koneksahealth.comCorporate Office
- One World Trade Center
- 285 Fulton Street 77th Floor
- New York, NY 10007
- United States
Corporate Office
- One World Trade Center
- 285 Fulton Street 77th Floor
- New York, NY 10007
- United States
Koneksa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 07-Feb-2022 | $45M | Completed | Clinical Trials - General | ||
| 4. Later Stage VC (Series B) | 03-Apr-2020 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | Completed | Clinical Trials - General | ||||
| 2. Seed Round | 21-Jun-2017 | $500K | $1.15M | Completed | Clinical Trials - General | |
| 1. Seed Round | $650K | $650K | Completed | Startup |
Koneksa Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed 2 | 69,096 | $0.000010 | $7.24 | $7.24 | 1x | $7.24 | 1.87% | |
| Seed 1 | 126,835 | $0.000010 | $5.43 | $5.43 | 1x | $5.43 | 3.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Koneksa Comparisons
Industry
Financing
Details
Koneksa Competitors (37)
One of Koneksa’s 37 competitors is TriNetX, a Private Equity-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TriNetX | Private Equity-Backed | Cambridge, MA | ||||
| Trapelo Health | Formerly VC-backed | Fort Myers, FL | ||||
| HealthMode | Formerly VC-backed | San Francisco, CA | ||||
| Trials.ai | Venture Capital-Backed | Princeton, NJ | ||||
| SeamlessMD | Venture Capital-Backed | Welland, Canada |
Koneksa Patents
Koneksa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230181060-A1 | Measuring method and device | Inactive | 13-Dec-2021 | ||
| US-20240324945-A1 | Measuring method and device | Pending | 13-Dec-2021 | ||
| CA-3238127-A1 | Movement measuring method and device | Pending | 13-Dec-2021 | ||
| EP-4447802-A1 | Movement measuring method and device | Pending | 13-Dec-2021 | ||
| WO-2023111534-A1 | Movement measuring method and device | Inactive | 13-Dec-2021 | A61B5/1121 |
Koneksa Signals
Koneksa Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Matrix Capital Management | Hedge Fund | Minority | ||
| Shields Health Innovations | PE/Buyout | Minority | ||
| Takeda Ventures | Corporate Venture Capital | Minority | ||
| Velosity Capital | Venture Capital | Minority | ||
| dRx Capital Novartis | Venture Capital | Minority |
Koneksa FAQs
-
When was Koneksa founded?
Koneksa was founded in 2013.
-
Where is Koneksa headquartered?
Koneksa is headquartered in New York, NY.
-
What is the size of Koneksa?
Koneksa has 55 total employees.
-
What industry is Koneksa in?
Koneksa’s primary industry is Other Healthcare Technology Systems.
-
Is Koneksa a private or public company?
Koneksa is a Private company.
-
What is the current valuation of Koneksa?
The current valuation of Koneksa is .
-
What is Koneksa’s current revenue?
The current revenue for Koneksa is .
-
How much funding has Koneksa raised over time?
Koneksa has raised $71.2M.
-
Who are Koneksa’s investors?
Matrix Capital Management, Shields Health Innovations, Takeda Ventures, Velosity Capital, and dRx Capital Novartis are 5 of 11 investors who have invested in Koneksa.
-
Who are Koneksa’s competitors?
TriNetX, Trapelo Health, HealthMode, Trials.ai, and SeamlessMD are some of the 37 competitors of Koneksa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process